Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$9,152,316
+$393,542 QoQ
Shares Held
36,037
+0.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#1,170
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Texas Yale Capital Corp. holds $42,723,383 across 10 Drug Manufacturers - General names. JNJ ranks #2 (21.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
47,632 | $11,986,116 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
36,037 | $9,152,316 | |
| 3 | MRK |
Merck & Co., Inc.
|
58,713 | $7,544,620 | |
| 4 | LLY |
ELI LILLY & Co
|
5,751 | $6,897,922 | |
| 5 | AMGN |
Amgen Inc
|
10,322 | $3,737,802 | |
| 6 | NVO |
Novo Nordisk A S
|
22,899 | $1,097,778 | |
| 7 | BIIB |
Biogen Inc.
|
3,987 | $861,431 | |
| 8 | NVS |
Novartis AG
|
4,542 | $711,822 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,152,316 | 36,037 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $8,758,774 | 35,832 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $6,934,273 | 33,507 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $6,500,268 | 35,057 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $4,488,864 | 29,387 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $4,756,622 | 28,682 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $4,210,177 | 29,112 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,847,538 | 29,912 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $4,458,903 | 30,507 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $4,902,624 | 30,992 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $4,900,789 | 31,267 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,837,750 | 31,061 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $5,245,494 | 31,691 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $4,852,585 | 31,307 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $5,600,511 | 31,704 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $5,165,443 | 31,620 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $5,633,634 | 31,737 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $5,593,556 | 31,561 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $5,398,969 | 31,560 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $5,062,056 | 31,344 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $5,216,162 | 31,663 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $5,187,214 | 31,562 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $5,261,370 | 33,431 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $4,942,816 | 33,200 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $4,678,056 | 33,265 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $4,405,574 | 33,597 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||